Fish Protein Hydrolysate Market Trends 2023 | Growth, Share, Size, Demand and Future Scope 2028

The global fish protein hydrolysate market size reached US$ 304.7 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 404.5 Million by 2028, exhibiting a growth rate (CAGR) of 4.7% during 2023-2028.

IMARC Group, a leading market research company, has recently releases report titled “Fish Protein Hydrolysate Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global fish protein hydrolysate market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights

How big is the fish protein hydrolysate market?

Report AttributesDetails
Market Size in 2022US$ 304.7 Million
Market Forecast in 2028US$ 404.5 Million
Growth rate (2023 to 2028)CAGR of 4.7%
Base Year of the Analysis2022
Forecast Period2023-2028

What is fish protein hydrolysate?

Fish protein hydrolysate (FPH) refers to a bioactive compound produced by utilizing decomposed fish proteins. The compound is obtained by decomposing minced fish meat with enzymes, such as trypsin, pepsin, and chymotrypsin to break down the proteins into peptides and amino acids. Both salt and freshwater fishes, including anchovy, crustacean, tuna, salmon, and sardine, can be used to produce FPH. It acts as a rich source of fatty acids, which helps in maintaining cardiovascular health and blood pressure levels. FPH is typically used as a food binder, gelling agent, nutritional supplement, emulsifier, etc.

Request for a free sample copy of this report: https://www.imarcgroup.com/fish-protein-hydrolysate-market/requestsample

What are the growth prospects and trends in the fish protein hydrolysate industry?

The growing pharmaceutical industry worldwide is the primary factor driving market growth. Several health benefits associated with FPH, such as minimizing the risk of hypertension and developing lean muscle mass, have led to its utilization in sports nutrition and protein supplements. Furthermore, FPH is also used as an alternative hypoallergenic protein for infants suffering from glucose and lactose intolerance and treating Crohn’s Disease and Irritable Bowel Syndrome. Additionally, rising disposable income levels and the growing use of FPH in cosmetics for its anti-aging properties are further augmenting the global market.

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Technology:

  • Acid Hydrolysis
  • Autolytic Hydrolysis
  • Enzymatic Hydrolysis

Breakup by Form:

  • Liquid
  • Powder

Breakup by Fish Type:

  • Anchovy
  • Herrings
  • Menhaden
  • Sardine
  • Shads
  • Others

Breakup by Application:

  • Food
  • Pharmaceuticals
  • Animal Feed and Pet Food
  • Cosmetics
  • Others 

Who are the key players operating in the industry?

The report covers the major market players including:

  • Alaska Protein Recovery LLC
  • Bio-marine Ingredients Ireland Ltd.
  • Copalis
  • Dramm Corporation
  • Gelita AG
  • Great Pacific BioProducts Ltd.
  • Hofseth Biocare ASA
  • Janatha Fish Meal & Oil Products
  • SAMPI
  • Scanbio Marine Group AS
  • Symrise AG
  • United Fisheries Ltd.

Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/fish-protein-hydrolysate-market

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: sales@imarcgroup.com

Follow us on Twitter: @imarcglobal

LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/


rozer smith

46 Blog posts

Comments